NLRC5/MHC class I transactivator is a target for immune evasion in cancer von Yoshihama, Sayuri, Roszik, Jason, Downs, Isaac, Meissner, Torsten B., Vijayan, Saptha, Chapuy, Bjoern, Sidiq, Tabasum, Shipp, Margaret A., Lizee, Gregory A., Kobayashi, Koichi S.

Volltext

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy von Chaudhri, Apoorvi, Bu, Xia, Wang, Yunfei, Gomez, Michael, Torchia, James A, Hua, Ping, Hung, Shao-Hsi, Davies, Michael A, Lizee, Gregory A, von Andrian, Ulrich, Hwu, Patrick, Freeman, Gordon J

Volltext

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy von Lyons, Yasmin A, Pradeep, Sunila, Wu, Sherry Y, Haemmerle, Monika, Hansen, Jean M, Wagner, Michael J, Villar-Prados, Alejandro, Nagaraja, Archana S, Dood, Robert L, Previs, Rebecca A, Hu, Wei, Zhao, Yang, Mak, Duncan H, Xiao, Zhilan, Melendez, Brenda D, Lizee, Gregory A, Mercado-Uribe, Imelda, Baggerly, Keith A, Hwu, Patrick, Liu, Jinsong, Overwijk, Willem W, Coleman, Robert L, Sood, Anil K

Volltext

Personalized Therapy: Tumor Antigen Discovery for Adoptive Cellular Therapy von Yee, Cassian, Lizee, Gregory A

Volltext

Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention von Bolivar, Ana M., Duzagac, Fahriye, Deng, Nan, Reyes-Uribe, Laura, Chang, Kyle, Wu, Wenhui, Bowen, Charles M., Taggart, Melissa W., Thirumurthi, Selvi, Lynch, Patrick M., You, Y. Nancy, Rodriguez-Pascual, Jesus, Lipkin, Steven M., Kopetz, Scott, Scheet, Paul, Lizee, Gregory A., Reuben, Alexandre, Sinha, Krishna M., Vilar, Eduardo

Volltext

Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease von Chen, Chao-Hsien, Chin, Renee L, Hartley, Genevieve P, Lea, Spencer T, Engel, Brian J, Hsieh, Cheng-En, Prasad, Rishika, Roszik, Jason, Shingu, Takashi, Lizee, Gregory A, Heimberger, Amy B, Millward, Steven W, Hu, Jian, Hong, David S, Curran, Michael A

Volltext

808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy von Chaudhri, Apoorvi, Bu, Xia, Wang, Yunfei, Hua, Ping, Hung, Shao-Hsi, Davies, Michael A, Lizee, Gregory A, Andrian, Ulrich von, Hwu, Patrick, Freeman, Gordon

Volltext

Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models von Zhu, Kuichun, Qin, Hong, Cha, Soung-Chul, Neelapu, Sattva S, Overwijk, Willem, Lizee, Gregory A, Abbruzzese, James L, Hwu, Patrick, Radvanyi, Laszlo, Kwak, Larry W, Chang, David Z

Volltext

Abstract 1705: Identification and validation of neoantigens for developing a preventive vaccine for mismatch-repair deficient cancers von Bowen, Charles, Bolivar, Ana, Chang, Kyle, Wu, Wendy, Reyes-Uribe, Laura, Lizee, Gregory A., Sinha, Krishna, Vilar, Eduardo

Volltext

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity von Hailemichael, Yared, Johnson, Daniel H., Abdel-Wahab, Noha, Foo, Wai Chin, Bentebibel, Salah-Eddine, Daher, May, Haymaker, Cara, Wani, Khalida, Saberian, Chantal, Ogata, Dai, Kim, Sang T., Nurieva, Roza, Lazar, Alexander J., Abu-Sbeih, Hamzah, Fa'ak, Faisal, Mathew, Antony, Wang, Yinghong, Falohun, Adewunmi, Trinh, Van, Zobniw, Chrystia, Spillson, Christine, Burks, Jared K., Awiwi, Muhammad, Elsayes, Khaled, Soto, Luisa Solis, Melendez, Brenda D., Davies, Michael A., Wargo, Jennifer, Curry, Jonathan, Yee, Cassian, Lizee, Gregory, Singh, Shalini, Sharma, Padmanee, Allison, James P., Hwu, Patrick, Ekmekcioglu, Suhendan, Diab, Adi

Volltext

T-CELL RECEPTORS TARGETING HER2 AND METHODS OF USE THEREOF von LIZEE, Gregory A, REUBEN, Alexandre, NIE, Hui, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12V MUTATION ON HLA-A11:01 IN LUNG CANCER von LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12C MUTATION ON HLA-A03:01 IN LUNG CANCER von LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12V MUTATION ON HLA-A03:01 IN LUNG CANCER von LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12C MUTATION ON HLA-A11:01 IN LUNG CANCER von LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12C MUTATION ON HLA-A11:01 IN LUNG CANCER von LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12V MUTATION ON HLA-A11:01 IN LUNG CANCER von LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12V MUTATION ON HLA-A03:01 IN LUNG CANCER von LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12C MUTATION ON HLA-A03:01 IN LUNG CANCER von LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin

Volltext bestellen

Animal Cell Biotechnology: Methods and Protocols von Jenkins, Nigel

Volltext